Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Burkitt Lymphoma × polatuzumab vedotin × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, Non-Hodgkin 3 Lymphoma 3 Lymphoma, Follicular 2 Lymphoma, B-Cell 2 Recurrence 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Cyclophosphamide 59 Rituximab 37 fludarabine phosphate 32 Whole-Body Irradiation 32 Methotrexate 31 Vincristine 29 Peripheral Blood Stem Cell Transplantation 26 Etoposide 26 Mycophenolic Acid 25 Cytarabine 24 Prednisone 21 Doxorubicin 20 Busulfan 20 merphos 19 Tacrolimus 19 Dexamethasone 19 Filgrastim 18 Cyclosporine 17 Calcium Dobesilate 17 Radiotherapy 15 Granulocyte Colony-Stimulating Factor 15 Antilymphocyte Serum 15 Melphalan 14 dexamethasone acetate 13 dexamethasone 21-phosphate 13 prednylidene 12 deltacortene 12 auricularum 12 azathiopurine 11 Mercaptopurine 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡